Drugs Flashcards
Metformin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD
A. Biguanides
Alogliptin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD
B. DPP-4 Inhibitors
Sitagliptin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD
B. DPP-4 Inhibitors
Dulaglutide
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD
C. GLP-1 Agonist
Liraglutide
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD
C. GLP-1 Agonist
Semaglutide
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD
C. GLP-1 Agonist
Dapagliflozin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD
E. SGLT-2 Inhibitor
Empagliflozin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD
E. SGLT-2 Inhibitor
Glipizide
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD
F. Sufonylurea
Pioglitazone
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD
G. TZD
Which of the following are agents that enhance insulin secretion?
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD
F. Sulfonylurea
G. Meglitinides
Glyburide, Glipizide, and Glimepiride are examples of what medication group?
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD
F. Sulfonylurea
Nateglinide and Repaglinide are examples of what medication group?
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD
G. Meglitinides
Agents that enhance _____ secretion include sulfonylureas with (short/prolonged) duration of action vs meglitinides with a (short/prolonged) duration of action.
Agents that enhance insulin secretion include sulfonylureas with prolonged duration of action vs meglitinides with a short duration of action.
Agents that enhance the incretin effect
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD
B. DPP-4 Inhibitors
C. GLP-1 Agonist